Moreover, miR-29 variants, such as miR-29a-3p and miR-29b-3p, are linked not only to gut health but also to systemic conditions like sarcopenia, frailty, and type 2 diabetes, where elevated miR-29 expression affects insulin resistance, glucose homeostasis, and inflammation. Here, INS is linked to type 2 diabetes mellitus.